Literature DB >> 18749485

Chest diseases-important advances in clinical medicine: drug therapy for pulmonary hypertension.

P M Gold.   

Abstract

Entities:  

Year:  1984        PMID: 18749485      PMCID: PMC1011043     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  3 in total

1.  Augmentation of right ventricular performance in chronic obstructive pulmonary disease by terbutaline: a combined radionuclide and hemodynamic study.

Authors:  B N Brent; D Mahler; H J Berger; R A Matthay; L Pytlik; B L Zaret
Journal:  Am J Cardiol       Date:  1982-08       Impact factor: 2.778

Review 2.  Primary pulmonary hypertension.

Authors:  A P Fishman; G G Pietra
Journal:  Annu Rev Med       Date:  1980       Impact factor: 13.739

3.  Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension.

Authors:  J B Hermiller; D Bambach; M J Thompson; P Huss; M E Fontana; R D Magorien; D V Unverferth; C V Leier
Journal:  Ann Intern Med       Date:  1982-10       Impact factor: 25.391

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.